Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
50–70
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Between the ages of 50-70 and at least 1 year beyond menopause;
resting blood pressure \<140/90 mmHg;
plasma glucose concentrations \<110 mg/dL under fasting conditions;
BMI \< 35;
LDL cholesterol \< 160 mg/dL;
sedentary or recreationally active (\<3 days of vigorous aerobic exercise);
no use of OCs, HT, or other medications that might influence cardiovascular function;
nonsmokers;
no use of vitamin supplements, blood thinners or NSAIDS, or willing to stop use one month prior to and for the duration of the study;
not taking any other medications that would interact with E2 patch or resveratrol to confound interpretation of results.
You may not be if
history of or active E2-dependent neoplasms, acute liver or gallbladder disease, vaginal bleeding, venous thromboembolism, hypertriglyceridemia (≥ 150 mg/dL), and CVD;
known allergy to transdermal patch, or resveratrol;
history of stomach ulcer or bleeding;
other contraindications to HT or resveratrol.
other conditions for which individuals will be excluded from the study include: diabetes, active infection, history of seizures or disease that affects the nervous system or an abnormal resting ECG.
